These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29772697)

  • 21. A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series.
    Vaz RJ; Nayeem A; Santone K; Chandrasena G; Gavai AV
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3816-20. PubMed ID: 15993593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiling the interaction mechanism of quinoline/quinazoline derivatives as MCHR1 antagonists: an in silico method.
    Wu M; Li Y; Fu X; Wang J; Zhang S; Yang L
    Int J Mol Sci; 2014 Sep; 15(9):15475-502. PubMed ID: 25257526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
    Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
    Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CoMFA and CoMSIA studies on 5-hydroxyindole-3-carboxylate derivatives as 5-lipoxygenase inhibitors: generation of homology model and docking studies.
    Aparoy P; Suresh GK; Kumar Reddy K; Reddanna P
    Bioorg Med Chem Lett; 2011 Jan; 21(1):456-62. PubMed ID: 21084193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.
    Doddareddy MR; Cho YS; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3D-QSAR studies on thiazolidin-4-one S1P₁receptor agonists by CoMFA and CoMSIA.
    Qian C; Zheng J; Xiao G; Guo J; Yang Z; Huang L; Chao W; Rao L; Sun P
    Int J Mol Sci; 2011; 12(10):6502-16. PubMed ID: 22072901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.
    Dessalew N; Patel DS; Bharatam PV
    J Mol Graph Model; 2007 Mar; 25(6):885-95. PubMed ID: 17018257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of novel FLT-3 inhibitors based on dual-layer 3D-QSAR model and fragment-based compounds in silico.
    Shih KC; Lin CY; Chi HC; Hwang CS; Chen TS; Tang CY; Hsiao NW
    J Chem Inf Model; 2012 Jan; 52(1):146-55. PubMed ID: 22142286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D-QSAR-based design, synthesis and biological evaluation of 2,4-disubstituted quinoline derivatives as antimalarial agents.
    Vyas VK; Bhati S; Sharma M; Gehlot P; Patel N; Dalai S
    SAR QSAR Environ Res; 2023; 34(8):639-659. PubMed ID: 37651746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
    Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
    J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
    Sethi KK; Verma SM
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
    Zhang H; Li H; Ma Q
    J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models.
    Tong L; Guo L; Lv X; Li Y
    J Mol Graph Model; 2017 Jan; 71():1-12. PubMed ID: 27825025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors.
    Xie H; Qiu K; Xie X
    Int J Mol Sci; 2014 Nov; 15(11):20927-47. PubMed ID: 25405729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.
    da Cunha EF; Sippl W; de Castro Ramalho T; Ceva Antunes OA; de Alencastro RB; Albuquerque MG
    Eur J Med Chem; 2009 Nov; 44(11):4344-52. PubMed ID: 19616874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.
    Sharma RN; Thakar H; Vasu KK; Chaturvedi SC
    Acta Pharm; 2008 Sep; 58(3):335-45. PubMed ID: 19103570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative structure-activity relationship of rubiscolin analogues as delta opioid peptides using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA).
    Caballero J; Saavedra M; Fernández M; González-Nilo FD
    J Agric Food Chem; 2007 Oct; 55(20):8101-4. PubMed ID: 17803260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents.
    Murugesan V; Prabhakar YS; Katti SB
    J Mol Graph Model; 2009 Feb; 27(6):735-43. PubMed ID: 19117780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.
    Zheng M; Yu K; Liu H; Luo X; Chen K; Zhu W; Jiang H
    J Comput Aided Mol Des; 2006 Sep; 20(9):549-66. PubMed ID: 17103017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.